EventsCells, Cells and Nothing but Cells: Discoveries, Challenges and Directions
Published
This submission belongs to the session CELLS_S7. Cell Motility and Adhesion of the event Cells, Cells and Nothing but Cells: Discoveries, Challenges and Directions
Published date
16 Feb, 2023
Academic Editor
author-avatarAlexander E. Kalyuzhny
Citation
Alexander Dityatev, Regulation of extrasynaptic glutamatergic signaling by polysialylated NCAM in health and disease, in Proceedings of Cells, Cells and Nothing but Cells: Discoveries, Challenges and Directions, 6 March–8 March 2023, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Regulation of extrasynaptic glutamatergic signaling by polysialylated NCAM in health and disease

image
1. German Center for Neurodegenerative Diseases (DZNE), 39120, Magdeburg, Germany, Switzerland
2. Medical Faculty, Otto-von-Guericke-University of Magdeburg, 39120 Magdeburg, Germany
3. Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany
Abstract

The neural cell adhesion molecule NCAM is known to mediate cell-cell and cell-extracellular matrix (ECM) adhesion via homophilic and heterophilic interactions. During brain development, NCAM and associated glycan, polysialic acid (polySia), play important roles in cell migration, proliferation, neurite outgrowth and fasciculation, and synaptogenesis. In the adult rodent brain, NCAM regulates synaptic plasticity, learning, and memory. Dysregulated cortical expression of NCAM and polySia have been found in Alzheimer’s disease and schizophrenia. Our data demonstrate the essential role of polySia-NCAM in the balancing of signaling through synaptic/extrasynaptic NMDA receptors and highlight the therapeutic potential of short polySia fragments to restrain GluN1/GluN2B-mediated signaling in several animal models of neurological and psychiatric diseases.

Keywords
LTP
synaptic plasticity
polysialic acid
schizophrenia
Alzheimer’s disease
NMDA receptor
Blood flow diverts extracellular vesicles from endothelial degradative compartments to promote angiogenesis
Mesoderm subset derived from human pluripotent stem cells from diabetic and nondiabetics improve retinal pathology in a model of type 2 diabetes.